Immunomedics
Immunomedics is a biopharmaceutical company that develops and commercializes monoclonal antibody-based therapies for the treatment of cancer.
Business Model:
Revenue: $21.5M
Employees: 201-500
Rankings
Industries / Tags:
Detailed Immunomedics Information
Immunomedics was acquired by
Gilead Sciences.
The acquisition happend on 2020-09-13.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 300 The American Road
City: Morris Plains
State: NJ
Zip: 07950
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$0
Raised Total:$30M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Immunomedics is a biopharmaceutical company that develops and commercializes monoclonal antibody-based therapies for the treatment of cancer.
Contact Phone:
+19736058200
Contact Email:
Immunomedics went public on 4/19/1984 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
4/19/1984
Ticker Symbol:
IMMU
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2014 | Post-IPO Equity | $30M | 5/2017 | Private Placement | $125M | 1/2017 | Post-IPO Equity | 1 | - |
New Enterprise Associates New Enterprise Associates |
1/2017 | Post-IPO Equity | 1 | - |
New Enterprise Associates New Enterprise Associates |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
